NASDAQ:ABCL | Profit Breakdown | AbCellera Biologics Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$4.05M-$62.78M-$58.97M-$55.43M
2026-03-31$8.32M-$57.52M-$49.54M-$43.17M
2025-12-31$44.85M-$28.58M-$19.5M-$8.95M
2025-09-30$8.96M-$76.28M-$68.77M-$57.12M
2025-06-30$17.08M-$49.59M-$36.34M-$34.73M
2025-03-31$4.24M-$62.66M-$52.98M-$45.62M
2024-12-31$5.05M-$72.76M-$46.83M-$34.21M
2024-09-30$6.51M-$93.66M-$62.63M-$51.11M
2024-06-30$7.32M-$93.45M-$48.19M-$36.93M
2024-03-31$9.95M-$54.89M-$42.75M-$40.61M
2023-12-31$9.18M-$66.05M-$48.6M-$47.15M
2023-09-30$6.6M-$54.89M-$39.28M-$28.61M
2023-06-30$10.06M-$51.39M-$38M-$30.53M
2023-03-31$12.19M-$64.87M-$48.15M-$40.11M
2022-12-31$21.55M-$37.78M-$31.41M-$29.89M
2022-09-30$101.38M$37.74M$46.59M$26.62M
2022-06-30$45.92M-$8.4M-$6.89M-$6.79M
2022-03-31$316.58M$224.95M$230.81M$168.57M
2021-12-31$139.33M$81.55M$84.71M$59.95M
2021-09-30$5.51M-$28.1M-$24.97M-$21.38M
2021-06-30$27.64M-$7.03M-$2.07M-$2.32M
2021-03-31$202.74M$158.07M$161.49M$117.22M
2020-12-31$207.91M$160.78M$155.92M$117M
2020-09-30$9.36M-$1.77M-$2.69M-$2.69M
2020-06-30$11.23M-$854,000.00$6.7M$6.7M
2020-03-31$4.66M-$2.12M-$2.09M-$2.09M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$75.13M-$217.1M-$177.6M-$146.41M
2024-12-31$28.83M-$314.77M-$200.4M-$162.86M
2023-12-31$38.03M-$237.21M-$174.03M-$146.4M
2022-12-31$485.42M$216.51M$239.1M$158.52M
2021-12-31$375.2M$204.41M$219.15M$153.46M
2020-12-31$233.16M$156.03M$157.83M$118.92M
2019-12-31$11.61M-$4.12M-$2.21M-$2.21M